JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on December 13, 2002
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
277/51/49517    most recent
M209546200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berghagen, H.
Right arrow Articles by Saatcioglu, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berghagen, H.
Right arrow Articles by Saatcioglu, F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print October 17, 2002
J. Biol. Chem, 10.1074/jbc.M209546200
Submitted on September 17, 2002
Revised on October 17, 2002
Accepted on October 17, 2002

Corepressor SMRT functions as a coactivator for T3Ra from a negative hormone response element

Hege Berghagen, Erlend Ragnhildstveit, Kristin Krogstud, Gunnar Thuestad, James Aprilletti, and Fahri Saatcioglu

Biology Institute, Division of Molecular Cell Biology, University of Oslo, Oslo 0316

Corresponding Author: fahris{at}bio.uio.no

Nuclear receptors are ligand-modulated transcription factors that transduce the presence of lipophilic ligands into changes in gene expression. Nuclear receptor activity is regulated by ligand-induced interactions with coactivator or corepressor molecules. From a positive hormone response element (pHRE) and in the absence of hormone, corepressors SMRT and N-CoR are bound to some nuclear receptors, such as thyroid hormone and retinoic acid receptors (T3Rs and RARs), and mediate inhibition of basal levels of transcription. Ligand binding results in dissociation of corepressors and association of coactivators, resulting in the reversal of inhibition and a net activation of transcription. However, the role of cofactors on the activity of nuclear receptors from negative HREs (nHREs) is poorly understood. Here we show that corepressor SMRT can act as a potent coactivator for T3Ra from a nHRE. Mutagenesis of residues in the hinge region of T3Ra which block binding of SMRT inhibits ligand-independent transcriptional activation by T3Ra from a nHRE. These mutations also abrogate SMRT-mediated increase in transcriptional activity by T3Ra at a nHRE without significantly affecting ligand-dependent activation at a pHRE. Partial protease digestion coupled to the mobility shift assay indicate differences in the conformation of T3Ra-SMRT complexes bound to a pHRE versus a nHRE. These results suggest that allosteric changes resulting from binding of T3Ra to different response elements, i.e. pHREs versus nHREs, dictate whether a cofactor will function as a coactivator or a corepressor. This, in turn, greatly expands the repertoire of mechanisms used in modulating transcription without the need for expression of new regulatory molecules.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
T. J. Peterson, S. Karmakar, M. C. Pace, T. Gao, and C. L. Smith
The Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor (SMRT) Corepressor Is Required for Full Estrogen Receptor {alpha} Transcriptional Activity
Mol. Cell. Biol., September 1, 2007; 27(17): 5933 - 5948.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. M. Santos, V. Afonso, G. B. Barra, M. Togashi, P. Webb, F. A. R. Neves, N. Lomri, and A. Lomri
Negative Regulation of Superoxide Dismutase-1 Promoter by Thyroid Hormone
Mol. Pharmacol., September 1, 2006; 70(3): 793 - 800.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
M. Nygard, N. Becker, B. Demeneix, K. Pettersson, and M. Bondesson
Thyroid hormone-mediated negative transcriptional regulation of Necdin expression.
J. Mol. Endocrinol., June 1, 2006; 36(3): 517 - 530.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
W. Wan, B. Farboud, and M. L. Privalsky
Pituitary Resistance to Thyroid Hormone Syndrome Is Associated with T3 Receptor Mutants that Selectively Impair {beta}2 Isoform Function
Mol. Endocrinol., June 1, 2005; 19(6): 1529 - 1542.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Meng, P. Webb, Y.-F. Yang, M. Shuen, A. F. Yousef, J. D. Baxter, J. S. Mymryk, and P. G. Walfish
E1A and a nuclear receptor corepressor splice variant (N-CoRI) are thyroid hormone receptor coactivators that bind in the corepressor mode
PNAS, May 3, 2005; 102(18): 6267 - 6272.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-W. Kim, S.-C. Ho, S.-J. Hong, K. M. Kim, E. C. So, M. Christoffolete, and J. W. Harney
A Novel Mechanism of Thyroid Hormone-dependent Negative Regulation by Thyroid Hormone Receptor, Nuclear Receptor Corepressor (NCoR), and GAGA-binding Factor on the Rat CD44 Promoter
J. Biol. Chem., April 15, 2005; 280(15): 14545 - 14555.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Cote, S. McNamara, D. Brambilla, A. Bianchini, G. Rizzo, S. V. del Rincon, F. Grignani, C. Nervi, and W. H. Miller Jr
Expression of SMRT{beta} promotes ligand-induced activation of mutated and wild-type retinoid receptors
Blood, December 15, 2004; 104(13): 4226 - 4235.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Ishii, M. Yamada, T. Satoh, T. Monden, K. Hashimoto, N. Shibusawa, K. Onigata, A. Morikawa, and M. Mori
Aberrant Dynamics of Histone Deacetylation at the Thyrotropin-Releasing Hormone Gene in Resistance to Thyroid Hormone
Mol. Endocrinol., July 1, 2004; 18(7): 1708 - 1720.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.